Doctor of Pharmacy (Pharm.D.) Program

UH Hilo > DKICP Home > Academic Programs

The Daniel K. Inouye College of Pharmacy (DKICP) at the University of Hawai’i at Hilo offers a four-year program of study leading to the Doctor of Pharmacy (Pharm.D.) degree.

DKICP accepts 80-90 students annually for Fall admissions, of which approximately 50% are residents of Hawaii.

Pharm.D. Admission Requirements for Fall 2016

PharmCAS Regular Application Deadline: February 1, 2016
PharmCAS Early Decision Deadline: September 8, 2015

Meeting the minimum qualification requirements does not guarantee admission. All eligible applications are reviewed by the DKICP Admissions Committee which applies multiple criteria to assess applications and select candidates to be interviewed.

To be eligible for consideration, students must complete the following:

  • Prerequisite Courses: Students must complete all prerequisite coursework before August 15, 2016. Admission is contingent upon the successful completion of all prerequisite courses with a minimum grade of "C" (C- grades are not accepted). Students may be in the process of completing prerequisite coursework at the time of application.
  • DKICP utilizes the overall and science GPAs calculated by PharmCAS. There are no minimum GPA requirements for admission. However, the average overall cumulative GPA for accepted students is 3.1. See PharmCAS GPA calculation policies.

    International Applicants must have foreign transcripts evaluated by WES, ECE, or Josef Silny & Associates. In addition, international applicants must also complete a minimum of 30 semester hours of coursework in the United States at any regionally-accredited college or university. Of the 30 required semester hours, 15 semester hours must be allocated to non-remedial science courses.

    Required Prerequisite Courses Semester Hours Quarter Hours
    General Biology I & II for Science Majors with Labs 8 12
    Microbiology with Labs 4 6
    General Chemistry I & II for Science Majors with Labs 8 12
    Organic Chemistry I & II for Science Majors with Labs 8 12
    Human Anatomy & Physiology I & II with Labs 8 12
    Calculus 1 or Advanced Calculus 3 4.5
    English (including 3 credits composition) 6 9
    Humanities 6 9
    A course that includes a World/Cultural Diversity component 3 4.5
    Social/Behavioral Sciences 6 9
    Economics 3 4.5
    Communications (with a public speaking component) 3 4.5
    Total Credit Hours 66 99
  • Pharmacy College Admission Test (PCAT): The PCAT is required for applying to the DKICP. The DKICP will not accept any other admission test in place of the PCAT. All PCAT scores must be sent to PharmCAS. Select PCAT code 104. DO NOT send scores directly to UH Hilo. Scores sent directly to UH Hilo will not be reviewed or considered. Applicants are encouraged to take the PCAT in July or September of the application year or earlier. January 2016 PCAT scores will be reviewed, however chances to receive an interview and subsequent offer are reduced significantly if a candidate has not taken the PCAT before January 2016. Results of PCAT exams taken prior to 2011 will not be considered.

  • PharmCAS Application: Students must apply and submit a complete application through PharmCAS. A complete application includes a personal statement, PCAT scores (if applicable), two professional letters of recommendation [electronic letters of reference (eLORs) are acceptable], applicable fee(s), and official transcripts from all regionally-accredited colleges and/or universities attended. DO NOT send letters of recommendation directly to UH Hilo. Letters of Recommendation sent directly to UH Hilo will not be reviewed or considered. PharmCAS applications are accepted from mid-July 2015 - February 1, 2016.

    Early Decision Deadline (September 8, 2015): DKICP will participate in the PharmCas Early Decision Program which is a binding option for applicants who have decided that a particular pharmacy degree program is their first choice and that they will enroll if accepted. As an Early Decision applicant, you can apply to only one pharmacy degree program. Eligible applicants will be invited to an in-person interview in Hilo during the month of October. You may be offered early admission, denied admission, or deferred to regular applicant status. If you are offered admission as an Early Decision applicant, you are obligated to accept the offer and you will not be permitted to apply to other PharmCAS institutions. If, however, you are denied admission as an Early Decision applicant or deferred to regular applicant status, you may apply to other PharmCAS institutions for an additional fee. Early decision applicants will receive an admission decision by October 23, 2015

  • Supplemental Application: Upon receipt of an applicant’s verified PharmCAS application, the DKICP Admissions Committee will formally request, via email, that the applicant complete a supplemental application, technical standards form, and residency declaration form, as well as submit a non-refundable $50.00 application fee. This "Supplemental Application Request" email will provide electronic links to the application and forms and will have instructions for completing these documents. A due date will be indicated in the email. Applicants are strongly advised to check their junk/spam mail folders regularly. Please note that applications will not be considered until all completed components of the application are received by DKICP.

    IMPORTANT: PharmCAS processing may take up to five weeks after an application, transcripts, and payment is received. Check your PharmCAS application status on-line. To view the real-time progress of your PharmCAS application, login to your PharmCAS application and select the STATUS menu option. Once PharmCAS has electronically transferred an application to us, the applicant should receive our "Supplemental Application Request" email within 14 business days. If you do not hear from us at this time, feel free to call us to check on the status of your application. However, please make sure you know the status of your PharmCAS application first.

DKICP operates on a competitive, rolling admissions process. Early submission is strongly recommended. Applicants are responsible for tracking the progress of their application and verifying that all necessary documents have been received by the UH Hilo DKICP Office of Student Services. The application review process begins in August 2015 and continues until all seats are filled. Upon receipt of all required application components noted above, the complete file and applicant profile will be reviewed by the DKICP Admissions Committee. At that time, the committee will decide to invite the candidate for an interview, place the candidate on hold for further review, or reject the applicant. Eligible students will be invited for a personal interview and are contacted via email. DKICP conducts closed file interviews. In closed file interviews, the interviewer is not provided with any information about the candidate except for their name. This approach was selected by the Admissions Committee as it helps remove preconceived biases based on students' experiences, grades, test scores, personal statements, etc. Interviews are conducted from December through May with additional interviews as needed. Interviews will be held in Hilo and this year interviews will also be offered in Las Vegas, NV in December 2015, Downey, CA in January 2016 and Anaheim, CA in March 2016. Complete applications and interview scores are reviewed by the Admissions Committee for final admission decisions. Accepted students will be notified by email.

Learn more about the Step-by-Step Application Process .

University of Hawaii Residency Regulations

Please see Questions and Answers About the University of Hawaiʻi's Residency Requirements for Tuition Purposes. Please review this information carefully and note that moving to Hawaiʻi solely for educational purposes is not, by itself, sufficient to establish residency.


Please review our frequently asked questions page where many of your questions can be answered. You may also email or call us at (808) 932-7140.